GSK vs TYGO · P/E 13, $103.31B cap vs P/E 45, rev $50.6M
GlaxoSmithKline PLC ADR (GSK) versus Tigo Energy Inc. (TYGO) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Tigo Energy Inc. (TYGO) is a solar company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported TYGO revenue for 2026-06-30 was $50.6M. Net income was $424.0K. TYGO currently screens at market cap $203.4M and trailing P/E 44.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TYGO currently screens at market cap $203.4M and trailing P/E 44.7.
Not investment advice. Open the GSK and TYGO stock pages for the full models.
Not investment advice.